Patrick L. McGeer

Active 1961–2020

Also published as
Patrick-L McGeer
199
Papers
45,012
Citations
122
h-index
198
i10-index

Citations

Citations per year for Patrick L. McGeer1967: 3 citations1968: 3 citations1969: 5 citations1970: 8 citations1971: 21 citations1972: 15 citations1973: 31 citations1974: 28 citations1975: 45 citations1976: 59 citations1977: 80 citations1978: 88 citations1979: 89 citations1980: 94 citations1981: 92 citations1982: 100 citations1983: 131 citations1984: 127 citations1985: 101 citations1986: 147 citations1987: 110 citations1988: 104 citations1989: 125 citations1990: 142 citations1991: 133 citations1992: 199 citations1993: 207 citations1994: 246 citations1995: 247 citations1996: 268 citations1997: 246 citations1998: 298 citations1999: 352 citations2000: 487 citations2001: 467 citations2002: 543 citations2003: 424 citations2004: 443 citations2005: 477 citations2006: 531 citations2007: 506 citations2008: 576 citations2009: 544 citations2010: 585 citations2011: 560 citations2012: 511 citations2013: 423 citations2014: 485 citations2015: 424 citations2016: 374 citations2017: 352 citations2018: 335 citations2019: 858 citations2020: 1,003 citations2021: 930 citations2022: 720 citations2023: 486 citations2024: 584 citations2025: 268 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,472 citing papers, 31.5% of this breakdownUnited Kingdom: 1,268 citing papers, 7.3% of this breakdownChina: 1,153 citing papers, 6.6% of this breakdownCanada: 959 citing papers, 5.5% of this breakdownGermany: 920 citing papers, 5.3% of this breakdownItaly: 737 citing papers, 4.2% of this breakdownJapan: 683 citing papers, 3.9% of this breakdownFrance: 509 citing papers, 2.9% of this breakdownAustralia: 483 citing papers, 2.8% of this breakdownSpain: 469 citing papers, 2.7% of this breakdownSouth Korea: 372 citing papers, 2.1% of this breakdownSweden: 356 citing papers, 2.1% of this breakdown
0%31.5%Other 23.1%

Fields

  • Medicine48.7%
  • Neuroscience32%
  • Biochemistry, Genetics and Molecular Biology12.3%
  • Immunology and Microbiology2.7%
  • Nursing0.8%
  • Agricultural and Biological Sciences0.6%
  • Other2.9%

Topics

  • Alzheimer's disease research and treatments10.5%
  • Neuroinflammation and Neurodegeneration Mechanisms10.1%
  • Parkinson's Disease Mechanisms and Treatments5.5%
  • Neuroscience and Neuropharmacology Research5.1%
  • Tryptophan and brain disorders2.6%
  • Cholinesterase and Neurodegenerative Diseases2%
  • Other64.2%

Coauthors

All papers

Open in search
  1. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

    Authors: , , , - Neurology 1988 cited by 2,998

  2. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

    Authors: , - Acta Neuropathologica 2013 cited by 476

  3. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR

    Authors: , , , - Neuroscience Letters 1987 cited by 836

  4. Inflammation and neurodegeneration in Parkinson's disease

    Authors: , - Parkinsonism & Related Disorders 2004 cited by 627

  5. Complement activation by beta-amyloid in Alzheimer disease.

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1992 cited by 814

  6. Astrocytes are GABAergic cells that modulate microglial activity

    Authors: , , - Glia 2010 cited by 319

  7. Colocalization of Transactivation-Responsive DNA-Binding Protein 43 and Huntingtin in Inclusions of Huntington Disease

    Authors: , , , , - Journal of Neuropathology & Experimental Neurology 2008 cited by 272

  8. Glial reactions in Parkinson's disease

    Authors: , - Movement Disorders 2007 cited by 702

  9. Inflammation and the Degenerative Diseases of Aging

    Authors: , - Annals of the New York Academy of Sciences 2004 cited by 522

  10. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K

    Authors: , , , - Brain Research 1990 cited by 447

  11. NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies

    Authors: , - Neurobiology of Aging 2006 cited by 489

  12. Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys

    Authors: , , , , , , - Experimental Neurology 2005 cited by 255

  13. Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson’s Disease

    Authors: , , , , , , , , , - Neurochemical Research 2016 cited by 127

  14. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease

    Authors: , , - Neurology 1996 cited by 1,371

  15. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

    Authors: , , , , , , , , , , , , , - Neurobiology of Aging 2008 cited by 230

  16. Inflammation, Antiinflammatory Agents, and Alzheimer’s Disease: The Last 22 Years

    Authors: , , - Journal of Alzheimer s Disease 2016 cited by 208

  17. Rate of cell death in parkinsonism indicates active neuropathological process

    Authors: , , , - Annals of Neurology 1988 cited by 563

  18. Aβ and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer’s disease

    Authors: , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 267

  19. Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases

    Authors: , , , , , - The FASEB Journal 2010 cited by 239

  20. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide

    Authors: , , , - Neuroscience Letters 2001 cited by 351

  21. Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins

    Authors: , , - Acta Neuropathologica 1992 cited by 234

  22. A Method for Diagnosing Alzheimer’s Disease Based on Salivary Amyloid-β Protein 42 Levels

    Authors: , , , , - Journal of Alzheimer s Disease 2016 cited by 109

  23. Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer’s disease dementia from normal controls: preliminary findings

    Authors: , , , , , , - BMC Neurology 2018 cited by 103

  24. Clinical trial of indomethacin in Alzheimer's disease

    Authors: , , , , , , , , , , - Neurology 1993 cited by 999